Abbot Financial Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.46M | Sell |
37,071
-696
| -2% | -$80.4K | 1.86% | 12 |
|
|
2025
Q4 | $3.98M | Buy |
37,767
+779
| +2% | +$73.1K | 1.65% | 13 |
|
|
2025
Q3 | $3.1M | Buy |
36,988
+2,811
| +8% | +$232K | 1.33% | 19 |
|
|
2025
Q2 | $2.71M | Buy |
34,177
+2,187
| +7% | +$174K | 1.25% | 19 |
|
|
2025
Q1 | $2.87M | Sell |
31,990
-18
| -0.1% | -$1.68K | 1.49% | 18 |
|
|
2024
Q4 | $3.18M | Buy |
32,008
+506
| +2% | +$52.2K | 1.59% | 14 |
|
|
2024
Q3 | $3.58M | Buy |
31,502
+490
| +2% | +$58.2K | 1.8% | 11 |
|
|
2024
Q2 | $3.84M | Sell |
31,012
-146
| -0.5% | -$18.8K | 2.06% | 10 |
|
|
2024
Q1 | $4.11M | Sell |
31,158
-218
| -0.7% | -$26.9K | 2.27% | 8 |
|
|
2023
Q4 | $3.42M | Buy |
31,376
+1,077
| +4% | +$112K | 2.06% | 10 |
|
|
2023
Q3 | $3.12M | Sell |
30,299
-972
| -3% | -$105K | 2.1% | 10 |
|
|
2023
Q2 | $3.61M | Sell |
31,271
-959
| -3% | -$109K | 2.32% | 9 |
|
|
2023
Q1 | $3.43M | Sell |
32,230
-674
| -2% | -$72.8K | 2.3% | 7 |
|
|
2022
Q4 | $3.65M | Sell |
32,904
-2,298
| -7% | -$235K | 2.5% | 4 |
|
|
2022
Q3 | $3.03M | Buy |
35,202
+76
| +0.2% | +$6.79K | 2.16% | 8 |
|
|
2022
Q2 | $3.2M | Buy |
35,126
+202
| +0.6% | +$17.9K | 1.94% | 10 |
|
|
2022
Q1 | $2.87M | Sell |
34,924
-49
| -0.1% | -$3.86K | 1.4% | 26 |
|
|
2021
Q4 | $2.68M | Sell |
34,973
-1,376
| -4% | -$110K | 1.2% | 27 |
|
|
2021
Q3 | $2.73M | Sell |
36,349
-374
| -1% | -$28.4K | 1.24% | 24 |
|
|
2021
Q2 | $2.86M | Sell |
36,723
-1,497
| -4% | -$111K | 1.25% | 20 |
|
|
2021
Q1 | $2.81M | Buy |
38,220
+1,238
| +3% | +$91.3K | 1.28% | 19 |
|
|
2020
Q4 | $2.89M | Buy |
36,982
+525
| +1% | +$40.2K | 1.66% | 16 |
|
|
2020
Q3 | $2.89M | Buy |
36,457
+35
| +0.1% | +$2.74K | 1.87% | 13 |
|
|
2020
Q2 | $2.69M | Sell |
36,422
-416
| -1% | -$31.3K | 1.85% | 14 |
|
|
2020
Q1 | $2.71M | Buy |
36,838
+326
| +0.9% | +$25.6K | 2.2% | 8 |
|
|
2019
Q4 | $3.17M | Buy |
36,512
+1
| +0% | +$82 | 2.01% | 11 |
|
|
2019
Q3 | $2.93M | Sell |
36,511
-103
| -0.3% | -$8.26K | 2.09% | 10 |
|
|
2019
Q2 | $2.93M | Sell |
36,614
-1,356
| -4% | -$104K | 2.12% | 12 |
|
|
2019
Q1 | $3.01M | Sell |
37,970
-208
| -0.5% | -$15.6K | 2.34% | 10 |
|
|
2018
Q4 | $2.78M | Sell |
38,178
-1,047
| -3% | -$73.9K | 2.45% | 11 |
|
|
2018
Q3 | $2.65M | Buy |
39,225
+3
| +0% | +$191 | 1.98% | 12 |
|
|
2018
Q2 | $2.27M | Sell |
39,222
-732
| -2% | -$41.3K | 1.81% | 14 |
|
|
2018
Q1 | $2.08M | Buy |
39,954
+2,124
| +6% | +$115K | 1.67% | 18 |
|
|
2017
Q4 | $2.03M | Buy |
37,830
+2,018
| +6% | +$112K | 1.62% | 21 |
|
|
2017
Q3 | $2.16M | Buy |
35,812
+108
| +0.3% | +$6.55K | 1.8% | 18 |
|
|
2017
Q2 | $2.18M | Buy |
+35,704
| New | +$2.17M | 1.96% | 17 |
|
Other funds holding MRK
VCM
VPM
Abbot Financial Management's MRK Position: Q1 2026 in Review
Abbot Financial Management reduced its Merck (MRK) stake by 1.8% in Q1 2026, selling an estimated $80.4K and leaving 37,071 shares worth $4.46M. The position accounts for 1.86% of the portfolio, ranked #12.
Abbot Financial Management first reported a position in MRK in Q2 2017 and has held it in 36 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Abbot Financial Management held 37,071 shares of Merck worth $4.46M as of Q1 2026.
- Abbot Financial Management sold 696 Merck shares in Q1 2026, an estimated $80.4K.
- Merck made up 1.86% of Abbot Financial Management's portfolio in Q1 2026, its #12 holding.
- Abbot Financial Management first reported a position in Merck in Q2 2017 and has held it in 36 quarters since.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Abbot Financial Management's 13F filing for Q1 2026, filed 13 May 2026.